Investor's Business Daily - Investing RSS http://ift.tt/1vqGZql Large-cap stocks across a variety of sectors continue to hold up relatively well amid increasing higher-volume declines in the major averages and overall market uncertainty. Valeant Pharmaceuticals (VRX) is a new entrant to this week's list. The drugmaker has been trying to acquire Botox maker Allergan (AGN) since April to no avail. Allergan thinks Valeant's $53 billion hostile offer is too low. To thwart a possible takeover, Allergan has been in
No comments:
Post a Comment